Sex, M/F | 17/0 |
Age, yr | 73.5 ± 5.7 (61-79) |
BMI | 22.3± .5 (16.8 – 30.5) |
Smoker/ever-smoker/Nonsmoker | 5/12/0 |
GOLD Stage (I/II/III/IV) | 1/6/6/4 |
FVC, L | 1.7 ± 0.1 |
FVC, % predicted | 54.5 ± 13.2 |
FEV1, L | 0.9 ± 0.1 |
FEV1, % predicted | 43.1 ± 16.2 |
FEV1/FVC | 52.6 ± 9.9 |
BODE Index | 4.1 ± 1.6 (0-7) |
6MWT | |
Distance, m | 380.6 ± 51.9 (272-468) |
Baseline dyspnea Borg score | 1 (0-3) |
Post-exercise Dyspnea Borg Score | 4.9 (3-8) |
Baseline IC, L | 1.15 ± 0.37 |
Post-exercise IC, L | 1.16 ± 0.35 |
SaO2 | 95.4 ± 1.6 |
HRCT Emphysema Score | 17.1 ± 14.9 (2-51) |
0-10 | 8 |
11-20 | 4 |
21-30 | 3 |
> 30 | 2 |
CPET | |
AT (Aerobic Threshold), ml/kg/min | 4.6 ± 1.9 |
AT VO2, ml/min | 621.1 ± 120.0 |
AT VCO2, ml/min | 595.1 ± 110.0 |
VO2max, ml/min | 757.1 ± 168.8 |